Status of 25-hydroxyvitamin D deficiency and effect of vitamin D receptor gene polymorphisms on bone mineral density in thalassemia patients of North India

Hematology

Volumn 17, Issue 5, 2012, Pages 291-296

  Singh, Kritanjali ^a   Kumar, Ravindra ^a   Shukla, Anju ^a   Phadke, Shubha R ^a   Agarwal, Sarita ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

25 (OH) vitamin D; BMD; Bsmi; Foki; Taqi; Thalassemia

Indexed keywords

25 HYDROXYVITAMIN D;

25 HYDROXYVITAMIN D DEFICIENCY; ADOLESCENT; ARTICLE; BETA THALASSEMIA; BONE DENSITY; BSML GENE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; DUAL ENERGY X RAY ABSORPTIOMETRY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOKL GENE; GENE; GENETIC ASSOCIATION; HIP; HIP DISEASE; HUMAN; INDIA; LUMBAR SPINE; MALE; OSTEOPOROSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SPINE DISEASE; TAQL GENE; VITAMIN BLOOD LEVEL; VITAMIN D BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN D RECEPTOR GENE;

ADOLESCENT; ADULT; BONE DENSITY; CHILD; FEMALE; HUMANS; INDIA; MALE; OSTEOPOROSIS; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PREVALENCE; RECEPTORS, CALCITRIOL; THALASSEMIA; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84866063315     PISSN: 10245332     EISSN: 16078454     Source Type: Journal    
DOI: 10.1179/1607845412Y.0000000017     Document Type: Article

References (29)

1. Domrongkitchaiporn S, Sirikulchayanonta V, Angchaisuksiri P, Stitchantrakul W, Kanokkantapong C, Rajatanavin R. Abnormalities in bone mineral density and bone histology in thalassemia. J Bone Miner Res. 2003;18:1682-8.
2. Voskaridou E, Terpos E. New insights into the pathophysiology and management of osteoporosis in patients with beta thalassaemia. Br J Haematol. 2004;127:127-39.
3. Bischoff-Ferrari HA, Dietrich T, Orav EJ, Dawson-Hughes B. Positive association between 25-hydroxy vitamin D levels and bone mineral density: a population-based study of younger and older adults. Am J Med. 2004;116:634-9.
4. Meier C, Woitge HW, Witte K, Lemmer B, Seibel MJ. Supplementation with oral vitamin D3 and calcium during winter prevents seasonal bone loss: a randomized controlled open-label prospective trial. J Bone Miner Res. 2004;19:1221-30.
5. Kanan RM, Varanasi SS, Francis RM, Parker L, Datta HK. Vitamin D receptor gene start codon polymorphism (FokI) and bone mineral density in healthy male subjects. Clin Endocrinol. 2000;53:93-8.
6. Tajima O, Ashizawa N, Ishii T, Amagai H, Mashimo T, Liu LJ, et al. Interaction of the effects between vitamin D receptor poly- morphism and exercise training on bone metabolism. J Appl Physiol. 2000;88:1271-6.
7. Bell NH, Morrison NA, Nguyen TV, Eisman J, Hollis BW. ApaI polymorphisms of the vitamin D receptor predict bone density of the lumbar spine and not racial difference in bone density in young men. J Lab Clin Med. 2001;137:133-40.
8. Braga V, Sangalli A, Malerba G, Mottes M, Mirandola S, Gatti D, et al. Relationship among VDR (BsmI and FokI), COLIA1, and CTR polymorphisms with bone mass, bone turnover markers, and sex hormones in men. Calcif Tissue Int. 2002;70: 457-62.
9. Morrison NA, George PM, Vaughan T, Tilyard MW, Frampton CM, Gilchrist NL. Vitamin D receptor genotypes influence the success of calcitriol therapy for recurrent vertebral fracture in osteoporosis. Ann Intern Med. 2006;145:302-4.
10. Poncz M, Solowiejczyk D, Harpel B, Mory Y, Schwartz E, Surrey S. Construction of human gene libraries from small amounts of peripheral blood: analysis of beta-like globin genes. Hemoglobin. 1982;6:27-36.
11. Morrison NA, Qi JC, Tokita A, Kelly PJ, Crofts L, Nguyen TV, et al. Prediction of bone density from vitamin D receptor alleles. Nature. 1994;367:284-7.
12. Lundin AC, Söderkvist P, Eriksson B, Bergman-Jungeström M, Wingren S. Association of breast cancer progression with a vitamin D receptor gene polymorphism. South-East Sweden Breast Cancer Group. Cancer Res. 1999;59:2332-4.
13. Harris SS, Eccleshall TR, Gross C, Dawson-Hughes B, Feldman D. The vitamin D receptor start codon polymorphism (FokI) and bone mineral density in premenopausal American black and white women. J Bone Miner Res. 1997;12:1043-8.
14. Vichinsky EP. The morbidity of bone disease in thalassemia. Ann N Y Acad Sci. 1998;850:344-8.
15. Vogiatzi MG, Autio KA, Schneider R, Giardina PJ. Low bone mass in prepubertal children with thalassemia major: insights into the pathogenesis of low bone mass in thalassemia. J Pediatr Endocrinol Metab. 2004;17:1415-21.
16. Dresner Pollak R, Rachmilewitz E, Blumenfeld A, Idelson M, Goldfarb AW. Bone mineral metabolism in adults with beta-thalassaemia major and intermedia. Br J Haematol. 2000;111: 902-7.
17. Ferrara M, Matarese SM, Francese M, Borrelli B, Coppola A, Coppola L, et al. Effect of VDR polymorphisms on growth and bone mineral density in homozygous beta thalassaemia. Br J Haematol. 2002;117:436-40.
18. El-Edel RH, Ghonaim MM, Abo-Salem OM, El-Nemr FM. Bone mineral density and vitamin d receptor polymorphism in β-thalassemia major. Pak J Pharm Sci. 2010;23:89-96.
19. Hamed HM, Galal A, El Ghamrawy M, AbdEl Azeem K, A El Ghoroury E, Rasheed MA, et al. Vitamin D receptor poly- morphisms and indices of bone turnover and bone mass in Egyptian children with sickle cell disease. Res J Med Med Sci. 2010;5:1-7.
20. Nakamura K, Ueno K, Nishiwaki T, Okuda Y, Saito T, Tsuchiya Y, et al. Nutrition, mild hyperparathyroidism, and bone mineral density in young Japanese women. Am J Clin Nutr. 2005;82: 1127-33.
21. Vupputuri MR, Goswami R, Gupta N, Ray D, Tandon N, Kumar N. Prevalence and functional significance of 25-hydroxy-vitamin D deficiency and vitamin D receptor gene polymorph- isms in Asian Indians. Am J Clin Nutr. 2006;83:1411-9.
22. Pirinççioǧlu AG, Akpolat V, Köksal O, Haspolat K, Söker M. Bone mineral density in children with beta-thalassemia major in Diyarbakir. Bone. 2011;49(4):819-23.
23. Frisk P, Arvidson J, Ljunggren O, Gustafsson J. Decreased bone mineral density in young adults treated with SCT in childhood: the role of 25-hydroxyvitamin D. Bone Marrow Transpl. 2011; 47(5):657-62.
24. De Sanctis V, Borsari G, Brachi S, Gubellini E, Gamberini MR, Carandina G. A rare cause of heart failure in iron-overload tha-lassaemic patients-primary hypoparathyroidism. Georgian Med News. 2008;156:111-3.
25. Chatterton BE, Thomas CM, Schultz CG. Liver density measured by DEXA correlates with serum ferritin in patients with beta-thalassemia major. J Clin Densitom. 2003;6:283-8.
26. Wu W, Zhi XM, Li DF, Lin K, Xu L, Yang YH. Vitamin D receptor gene polymorphism is not associated with bone mineral density of pre-menopausal women in Guangzhou. Nan Fang Yi Ke Da Xue Xue Bao. 2007;27:364-6.
27. Spector TD, Keen RW, Arden NK, Morrison NA, Major PJ, Nguyen TV, et al. Influence of vitamin D receptor genotype on bone mineral density in postmenopausal women: a twin study in Britain. BMJ. 1995;310:1357-60.
28. Nguyen TV, Esteban LM, White CP, Grant SF, Center JR, Gardiner EM, et al. Contribution of the collagen I alpha 1 and vitamin D receptor genes to the risk of hip fracture in elderly women. J Clin Endocrinol Metab. 2005;90:6575-9.
29. Gogas Yavuz D, Keskin L, Kiyici S, Sert M, Yazici D, Sahin I, et al. Vitamin D receptor gene BsmI, FokI, ApaI, TaqI poly- morphisms and bone mineral density in a group of Turkish type 1 diabetic patients. Acta Diabetol. 2011;48(4):329-36.